Filter
1

A Study of APG-3288 in Relapsed/Refractory Blood Cancers

for
Relapsed/Refractory Hematological Malignancies,
Location: East Brunswick NJ, Grand Rapids MI, Los Angeles CA
Sponsor: Ascentage Pharma Group Inc.

Sex: All

Age: 18+

Code: NCT07424833

Phase1, Recruiting

HEME Home Transfusion Program

for
Leukemia, Myeloma, Myelodysplastic Syndromes,
Location: Boston MA
Sponsor: Dana-Farber Cancer Institute

Sex: All

Age: 18+

Code: NCT06487247

Recruiting

Pre-malignant States to Hematologic Malignancies in Firefighters

for
Clonal Hematopoiesis of Indeterminate Potential,
Location: Charlotte NC
Sponsor: Wake Forest University Health Sciences

Sex: All

Age: 40 - 49

Code: NCT06870760

Recruiting

Mosaic Trial for Stem Cell Transplant Recipients

for
Hematologic Malignancy, Stem Cell Transplant,
Location: Nutley NJ, Washington D.C. DC, Chicago IL
Sponsor: Northwestern University

Sex: All

Age: 18+

Code: NCT06960993

Recruiting

Infusion of Cell Populations From Unlicensed Umbilical Cord Blood Units

for
Lymphatic Diseases, Hematopoietic Malignancy
Location: Minneapolis MN
Sponsor: Masonic Cancer Center, University of Minnesota

Sex: All

Age: 0+

Code: NCT01451502

Recruiting

Interested in new hematopoietic and lymphatic system neoplasm trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image